- Report
- May 2024
- 130 Pages
Global
From €3676EUR$3,999USD£3,125GBP
- Report
- May 2024
- 129 Pages
Global
From €3676EUR$3,999USD£3,125GBP
- Report
- May 2024
- 138 Pages
Global
From €3676EUR$3,999USD£3,125GBP
- Report
- July 2024
- 120 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- October 2022
- 113 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- May 2025
- 114 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- July 2024
- 120 Pages
Global
From €4366EUR$4,750USD£3,712GBP
- Report
- June 2025
- 400 Pages
Global
From €4549EUR$4,949USD£3,868GBP
- Report
- June 2025
- 400 Pages
Global
From €4549EUR$4,949USD£3,868GBP
- Report
- June 2025
- 250 Pages
India
From €2564EUR$2,789USD£2,180GBP
- Report
- August 2024
- 200 Pages
Global
From €4549EUR$4,949USD£3,868GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3557EUR$3,869USD£3,024GBP
- Report
- June 2023
- 140 Pages
Global
From €4549EUR$4,949USD£3,868GBP
- Report
- April 2023
- 160 Pages
Global
From €4549EUR$4,949USD£3,868GBP
- Report
- June 2025
- 400 Pages
Global
From €4549EUR$4,949USD£3,868GBP
- Report
- July 2025
- 163 Pages
Global
From €13788EUR$14,999USD£11,722GBP
- Report
- April 2025
- 43 Pages
Global
From €1103EUR$1,200USD£938GBP
- Drug Pipelines
- February 2023
- 35 Pages
Global
From €18376EUR$19,990USD£15,623GBP
- Report
- January 2024
- 150 Pages
Global
€4592EUR$4,995USD£3,904GBP
- Report
- August 2025
- 152 Pages
Global
From €3631EUR$3,950USD£3,087GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more